Institute for nanoscience and nanotechnology, Sharif University of Technology, Tehran, Iran.
Nanotechnology and Tissue Engineering Department, Stem Cell Technology Research Center, Tehran, Iran.
J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1108-1120. doi: 10.1002/jbm.b.33923. Epub 2017 May 15.
In the present study, the feasibility of electrospun polyethersolfone (PES) nanofibrous membrane as the solid substrate for microfluidic based immunoassays to enhance the density of immobilized antibody on the surface of membrane was assessed. Conversely, the efficacy of antibody immobilization was compared by two different strategies as 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC)/N-Hydroxysuccinimide (NHS) coupling chemistry and hydrophobic interaction. Compared to conventional immunoassays carried out in plates or gels, microfluidic based immunoassays grant a lot of advantages such as a consumption of little samples and reagents, shorter analysis time, and higher efficiency. Therefore, microfluidic immunoassays can be efficiently used as a point-of-care device in medical diagnosis. Surprisingly, we found the increase of specific surface areas of the microfluidic channels improve density of immobilized proteins and leads to higher signal strength. Anti-staphylococcus enterotoxin B (anti-SEB) was used as an analyte model to demonstrate the utility of our proposed platform. Fluorescent microscopy, Fourier transform infrared spectroscopic (FTIR), gas adsorption, contact angle, X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), Uv-Vis spectrophotometer and atomic force microscopy (AFM) techniques were used to assess the efficacy of antibody immobilization on the surface. To understand dominant mechanism of protein immobilization, zeta potential measurement was also carried out and it was found electrostatic attraction play significant role in antibody immobilization running into micro- channels containing through EDC/NHS. Moreover, incorporation of nanofibrous membrane causes significant improvement in the signal detection of microfluidic based immunoassay. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1108-1120, 2018.
在本研究中,评估了将聚醚砜(PES)纳米纤维膜用作基于微流控的免疫测定的固体基底的可行性,以提高膜表面固定化抗体的密度。相反,通过两种不同的策略比较了抗体固定化的效果,即 1-乙基-3-(3-二甲基氨基丙基)碳化二亚胺(EDC)/N-羟基琥珀酰亚胺(NHS)偶联化学和疏水相互作用。与在平板或凝胶中进行的常规免疫测定相比,基于微流控的免疫测定具有许多优势,例如消耗的样品和试剂少、分析时间短、效率高。因此,微流控免疫测定可以有效地用作医疗诊断中的即时护理设备。令人惊讶的是,我们发现增加微流道的比表面积可以提高固定化蛋白质的密度,从而提高信号强度。抗葡萄球菌肠毒素 B(抗-SEB)被用作分析物模型来证明我们提出的平台的实用性。荧光显微镜、傅里叶变换红外光谱(FTIR)、气体吸附、接触角、X 射线光电子能谱(XPS)、扫描电子显微镜(SEM)、紫外-可见分光光度计和原子力显微镜(AFM)技术用于评估表面上抗体固定化的效果。为了了解蛋白质固定化的主要机制,还进行了 zeta 电位测量,结果发现静电吸引在包含 EDC/NHS 的微通道中运行时在抗体固定化中起着重要作用。此外,纳米纤维膜的掺入导致基于微流控的免疫测定的信号检测得到显著改善。©2017 威利父子公司。J 生物医学材料研究部分 B:应用生物材料,106B:1108-1120,2018 年。